We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Your Password has changed! Please login again
Cart
Outdated Browser Detected
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features.
Please use one of the below recommended browsers to improve your browsing experience
Working at West means being part of a culture of giving and working by the side of the communities where we operate. Our team members are passionate about making a difference and donate considerable time and resources through our corporate giving and volunteer programs. West’s giving strategy focuses on three elements: corporate giving through direct charitable gifts made by West Pharmaceutical Services, Inc., scholarships and matching gifts awarded through the Herman O. West Foundation, an independently managed 501(c)(3) entity and our team member-led giving program, West without Borders*.
West without Borders builds upon our culture of giving back to the communities in which we live and work. West team members regularly come together to give back to the local community. WestGives, our online portal, also offers team members the ability to search for volunteer opportunities in their community and track volunteer hours for West-sponsored events.
For many years, West has targeted its philanthropic efforts to support charities focused on children, people with disabilities, healthcare and education, with a focus on STEM (Science, Technology, Engineering and Math). Since the inception of West without Borders in 2004, team members at West’s sites have raised and donated more than $3 million dollars for a variety of charities around the world.
“We have a strong culture of giving back at West. Across all our sites, team members work together to support charities that have special meaning to them in their local communities. We are proud of how many of our team members support these important initiatives, and the impact we are making across the globe,” shared Emily Denney, VP Global Communications and Corporate Philanthropy.
This year, our commitment to giving back was evident through the impressive 65,969 pounds of food that was collected in just two weeks during our fourth annual Global Food Drive. That’s an impressive 9,000+ pounds more than we gathered last year to donate to local charities and food banks! To date, we’ve collected and distributed 191,693 pounds globally in our first four years.
The food gathered during this drive was donated to more than 40 charities and food banks around the world to fight hunger by helping those in need. Some recipients of our donations included:
St. Mary’s Food Bank Alliance, United States
Singapore Children’s Society, Singapore
The Salvation Army, United States
Eschweiler Tafel, Germany
Waterford Food Bank, Ireland
For more information about West and our culture of giving, please visit the Our Culture of Giving page on our website.
#WestByYourSide #WhyJoinWest
West without Borders is not affiliated with Doctors Without Borders®, which is a registered service mark of Bureau International de Médecins San Frontières.
Ensuring the sterility of sterile medicinal products has always been one of the key concerns of drug manufacturers, due to the dire health implications it could have on the patients, as well as the potential for costly product recalls. The importance of control strategies to ensure sterile drug products has also been reiterated by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and The European Medicines Agency (EMA) in their respective guidelines: <br /><ul><li>FDA – Sterile Drug Products Produced by Aseptic Processing – Current Good Manufacturing Practice</li><li>EU GMP Annex 1 Manufacture of Sterile Medicinal Products</li></ul>
The rise in type 2 diabetes has sparked a variety of treatment options, including glucagon-like peptide-1 (GLP-1) receptor agonists. GLP-1s are a class of injected drugs (additional oral options are currently in development) that “mimic the action of GLP-1 and increase the incretin effect in patients with type 2 diabetes, stimulating the release of insulin.”<sup>1</sup> Commonly used when oral treatment alone is not enough, the benefits of GLP-1s include a reduction of glucagon and glycosylated haemoglobin (HbA1c), weight loss and a low risk of hypoglycemia.<sup>2</sup>
West and its partner Daikyo have introduced a superior quality elastomeric piston the Daikyo D Sigma<sup>®</sup> 1mL long piston, substantially raising the standard for product acceptance. The D Sigma piston combines Daikyo best practices with a known formulation (D21-7H), Daikyo Flurotec<sup>®</sup> film, RB2 Coating, RSV<sup>®</sup> and RUV<sup>®</sup> processing with key innovation improvements of automated dimensional measurements, tight Acceptable Quality Levels (AQLs), particulate testing per ISO 8871-3, and enhanced vision inspection to achieve high levels of performance and consistency.
Drug shortages put patients at risk. Adverse health consequences can occur quickly when shortages make maintaining and/or complying to a therapeutic regimen difficult. In a recent <a href="http://www.nature.com/clpt/journal/v93/n2/full/clpt2012220a.html"><span style="color: #0000ff; text-decoration: underline;">paper</span></a>, Center for Drug Evaluation and Research (CDER) director, Janet Woodcock and her CDER colleague Marta Wosinska offered insight into the challenges CDER faces in choosing a course of compliance action when shortages of critical drugs occur. In the paper, CDER officials cited quality issues as the largest cause (56 percent) of drug shortages in 2011.
West presented a webinar: Navigating Particle Challenges in Sterile Drugs from Component to Patient by Fran DeGrazio, Vice-President, Scientific Affairs & Technical Services, and John Rech, Technology Manager – Particles, Analytical Lab Services, LLC. <br />